Patents by Inventor Joseph D. Mancias

Joseph D. Mancias has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for modulating NCOA4-mediated autophagic targeting of ferritin
    Patent number: 10350264
    Abstract: Described herein are methods of modulating autophagic targeting of ferritin in a cell, wherein the method comprises modulating the level and/or activity of nuclear receptor coactivator 4 (NCOA4) in the cell. Also provided are related methods of treatment.
    Type: Grant
    Filed: March 27, 2015
    Date of Patent: July 16, 2019
    Assignees: Dana-Farber Cancer Institute, Inc., President and Fellows of Harvard College, Beth Israel Deaconess Medical Center, Inc., The Brigham & Women's Hospital, Inc.
    Inventors: Alec C. Kimmelman, Joseph D. Mancias, Jeffrey Wade Harper
  • Compositions And Methods For Modulating NCOA4-Mediated Autophagic Targeting Of Ferritin
    Publication number: 20170182119
    Abstract: Described herein are methods of modulating autophagic targeting of ferritin in a cell, wherein the method comprises modulating the level and/or activity of nuclear receptor coactivator 4 (NCOA4) in the cell. Also provided are related methods of treatment.
    Type: Application
    Filed: March 27, 2015
    Publication date: June 29, 2017
    Inventors: Alec C. Kimmelman, Joseph D. Mancias, Jeffrey Wade Harper